BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 11072673)

  • 1. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
    Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
    Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
    Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
    Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
    Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
    Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
    J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
    Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
    Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W; Erhardt A; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.
    Seehofer D; Rayes N; Berg T; Neuhaus R; Hopf U; Müller AR; Bechstein WO; Neuhaus P
    Transplantation; 2000 Apr; 69(8):1739-42. PubMed ID: 10836394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
    Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
    Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
    Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.
    Potthoff A; Tillmann HL; Bara C; Deterding K; Pethig K; Meyer S; Haverich A; Böker KH; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Nov; 13(11):734-41. PubMed ID: 17052272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.